CUOMO, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 5.711
EU - Europa 5.699
AS - Asia 3.536
SA - Sud America 789
Continente sconosciuto - Info sul continente non disponibili 359
AF - Africa 244
OC - Oceania 42
Totale 16.380
Nazione #
US - Stati Uniti d'America 5.532
IT - Italia 1.954
SG - Singapore 1.172
RU - Federazione Russa 1.048
CN - Cina 973
GB - Regno Unito 942
BR - Brasile 624
IE - Irlanda 536
VN - Vietnam 372
HK - Hong Kong 270
FR - Francia 252
SE - Svezia 234
KR - Corea 185
DE - Germania 182
IN - India 151
UA - Ucraina 125
BD - Bangladesh 105
CA - Canada 102
FI - Finlandia 93
ZA - Sudafrica 92
AR - Argentina 70
NL - Olanda 70
TR - Turchia 65
MX - Messico 50
ES - Italia 47
KE - Kenya 47
PL - Polonia 40
AU - Australia 36
JP - Giappone 34
IQ - Iraq 31
AT - Austria 30
NG - Nigeria 25
CI - Costa d'Avorio 22
EC - Ecuador 22
CH - Svizzera 19
ID - Indonesia 19
PE - Perù 19
GR - Grecia 18
VE - Venezuela 18
PH - Filippine 16
PK - Pakistan 16
MA - Marocco 15
MY - Malesia 14
SA - Arabia Saudita 14
UZ - Uzbekistan 12
CO - Colombia 11
CZ - Repubblica Ceca 11
EG - Egitto 11
HU - Ungheria 11
CL - Cile 10
DK - Danimarca 10
IR - Iran 10
PT - Portogallo 10
TH - Thailandia 10
DZ - Algeria 8
PY - Paraguay 8
RO - Romania 8
IM - Isola di Man 7
TW - Taiwan 7
UG - Uganda 7
AE - Emirati Arabi Uniti 6
BE - Belgio 6
CR - Costa Rica 6
JO - Giordania 6
LT - Lituania 6
NO - Norvegia 6
NP - Nepal 6
OM - Oman 6
RS - Serbia 6
SK - Slovacchia (Repubblica Slovacca) 6
BG - Bulgaria 5
NZ - Nuova Zelanda 5
TN - Tunisia 5
AL - Albania 4
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
IL - Israele 4
KG - Kirghizistan 4
KZ - Kazakistan 4
UY - Uruguay 4
BF - Burkina Faso 3
JM - Giamaica 3
KW - Kuwait 3
MD - Moldavia 3
PR - Porto Rico 3
PS - Palestinian Territory 3
SI - Slovenia 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
BH - Bahrain 2
BO - Bolivia 2
CY - Cipro 2
GE - Georgia 2
GT - Guatemala 2
HR - Croazia 2
LB - Libano 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
Totale 16.004
Città #
Southend 771
Dallas 739
Singapore 550
Dublin 527
Ashburn 452
Milan 394
Santa Clara 374
Fairfield 358
Moscow 334
San Jose 325
Houston 268
Hefei 263
Hong Kong 249
Beijing 243
Siena 227
Chandler 191
Florence 182
Seoul 174
Council Bluffs 167
Rome 162
Woodbridge 158
Wilmington 140
Seattle 121
Cambridge 115
Ho Chi Minh City 103
Jacksonville 103
Los Angeles 101
The Dalles 94
New York 88
Princeton 78
Lauterbourg 75
Johannesburg 73
Dong Ket 71
Hanoi 69
São Paulo 66
Ann Arbor 63
Helsinki 56
Columbus 49
Munich 48
Bengaluru 41
Redondo Beach 41
Buffalo 40
Orem 37
Nairobi 34
Nanjing 33
Rio de Janeiro 33
Chicago 31
Naples 31
San Diego 31
San Mateo 29
Bologna 28
Turin 28
Figino 27
Boardman 26
London 26
Warsaw 25
Washington 25
Chennai 24
Málaga 24
Nuremberg 24
Abuja 23
Brescia 23
Montreal 23
San Francisco 23
Abidjan 22
Brooklyn 22
Tokyo 22
Sanliurfa 21
Toronto 21
Cinisello Balsamo 20
Lappeenranta 20
Prato 19
Amsterdam 18
Da Nang 18
Manchester 18
Mumbai 18
Palermo 17
Boston 16
Mexico City 16
Trento 16
Vienna 16
Campinas 15
Dhaka 15
Frankfurt am Main 15
Lima 15
Paris 15
Tianjin 15
Cape Town 14
Livorno 14
Shanghai 14
Stockholm 14
Denver 13
Sydney 13
Atlanta 12
Belo Horizonte 12
Guangzhou 12
North Bergen 12
Norwalk 12
Phoenix 12
Tashkent 12
Totale 9.927
Nome #
Trazodone: a multifunctional antidepressant. Evaluation of its properties and real-world use 575
Clinical effectiveness of parenteral trazodone for the management of psychomotor activation in patients with bipolar disorder 533
"TREATMENT-RESISTANT DEPRESSION" AND USE OF INTRAVENOUS KETAMINE AND INTRANASAL ES-KETAMINE 438
Asenapine for the treatment of manic and mixed episodes associated with bipolar I disorder: from clinical research to clinical practice 415
Diagnosis, Epidemiology and Management of Mixed States in Bipolar Disorder 377
Aripiprazole use during pregnancy, peripartum and lactation. A systematic literature search and review to inform clinical practice 310
Antidepressant and pro-motivational effects of repeated lamotrigine treatment in a rat model of depressive symptoms 295
The Microbiome: A New Target for Research and Treatment of Schizophrenia and its Resistant Presentations? A Systematic Literature Search and Review 287
Drug safety evaluation of aripiprazole in bipolar disorder 276
Feasibility, adherence and efficacy of liraglutide treatment in a sample of individuals with mood disorders and obesity 254
Advances in treatment for postpartum major depressive disorder 245
Prevalence and correlates of Vitamin D deficiency in a sample of 290 inpatients with mental illness 228
Effectiveness of light therapy as adjunctive treatment in bipolar depression: A pilot study 224
Treatment persistence in patients with schizophrenia treated with lurasidone in Italian clinical practice 217
Pharmacotherapeutic strategies for treating binge eating disorder. Evidence from clinical trials and implications for clinical practice 217
Prevalence, chronicity, burden and borders of bipolar disorder 215
A Systematic Review on Ketamine and Esketamine for Treatment-Resistant Depression and Suicidality in Adolescents: A New Hope? 212
Does higher severity really correlate with a worse quality of life in obsessive-compulsive disorder? A meta-regression 211
Therapeutic Potential of Saffron Extract in Mild Depression: A Study of Its Role on Anhedonia in Rats and Humans 209
A new approach for seasonal pattern: is it related to bipolarity dimension? Findings from an Italian multicenter study 208
S-Adenosylmethionine (SAMe) in major depressive disorder (MDD): A clinician-oriented systematic review 207
Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition 204
Internet use by older adults with bipolar disorder: international survey results 203
Using sertraline in postpartum and breastfeeding: balancing risks and benefits 202
Mood spectrum symptoms during a major depressive episode: Differences between 145 patients with bipolar disorder and 155 patients with major depressive disorder. Arguments for a dimensional approach 199
Perfenazina, amitriptilina e perfenazina-amitriptilina: Ruolo nella pratica clinica [Perphenazine, amitriptyline and perphenazine-amitriptyline: Role in clinical practice] 198
The neural bases of social cognition in major depressive disorder: a review [La cognizione sociale nel disturbo depressivo maggiore: Una rassegna sulle basi neurali] 197
Neuroticism and conscientiousness moderate the effect of oral medication beliefs on adherence of people with mental illness during the pandemic 196
On the centrality of mixed features in mood disorders: Listening to Kraepelin and Weygandt and moving forward 196
Clinical guidance for the use of trazodone in major depressive disorder and concomitant conditions: Pharmacology and clinical practice 194
Exploring treatment strategies for mood stabilization in patients with major depressive disorder and mixed features 193
Mental health in Italy after two years of COVID-19 from the perspective of 1281 Italian physicians: looking back to plan forward 190
Accuracy of self-assessment of real-life functioning in schizophrenia 186
The interplay among psychopathology, personal resources, context-related factors and real-life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non-recovered patients 182
Biomarkers, Inflammation, and Bipolar Disorder: Association Between the Improvement of Bipolar Disorder Severity and the Improvement in C-Reactive Protein Levels After 7 Days of Inpatient Treatment 179
Validation of the Oxford Depression Questionnaire: Sensitivity to change, minimal clinically important difference, and response threshold for the assessment of emotional blunting 178
Psychological interventions for post-traumatic stress disorder in women survivors of intimate partner violence: A systematic review and meta-analysis 177
Is intravenous valproate more efficacious than oral valproate for inpatients with bipolar I disorder with a manic or depressive episode and concomitant symptoms of opposite polarity? 174
Effectiveness and Tolerability of Supratherapeutic Dosing of Vortioxetine in Patients With Treatment-Resistant Depression 173
Efficacy of topiramate in treating obsessive compulsive disorder: A systematic review and meta-analysis 170
The impact of COVID-19 pandemic in patients with a diagnosis of Oral Lichen Planus: Pain perception and psychological profile analysis 169
Symptom modulation and tolerability of intravenous ketamine in treatment-resistant bipolar depression: A retrospective study 167
Safety of psychotropic medications in people with COVID-19: Evidence review and practical recommendations 162
Two-Injection Start Regimen of Long-Acting Aripiprazole in 133 Patients With Schizophrenia 158
Lamotrigine in bipolar disorder: preventing depression to treat the disease 157
Treating major depressive disorder with mixed features 154
La responsabilità dello psichiatra [Duties and liabilities for psychiatrists] 154
Five-year follow-up of first-episode depression treated with psychodynamic psychotherapy or antidepressants 153
Which mixed depression model? A comparison between DSM-5-defined mixed features and Koukopoulos' criteria 150
COVID-19 Diary from a Psychiatry Department in Italy 149
Lurasidone in adolescents and adults with schizophrenia: from clinical trials to real-world clinical practice 148
Perspectives on the impact of vortioxetine on the treatment armamentarium of major depressive disorder 146
Neurophysiological correlates of ketamine-induced dissociative state in bipolar disorder: insights from real-world clinical settings 143
Worldwide prevalence of obsessive-compulsive symptoms during the COVID-19 pandemic: A systematic review and meta-analysis 142
Treating schizophrenia with cariprazine: from clinical research to clinical practice. Real world experiences and recommendations from an International Panel 141
Association between polarity of first episode and solar insolation in bipolar I disorder 140
Practical guidance for prescribing trazodone extended-release in major depression 139
QTc interval diurnal variations in patients treated with psychotropic medications: implications for the evaluation of drug induced QTc changes 134
Exploration of mood spectrum symptoms during a major depressive episode: The impact of contrapolarity-Results from a transdiagnostic cluster analysis on an Italian sample of unipolar and bipolar patients 134
null 134
Disorganization and real-world functioning in schizophrenia: Results from the multicenter study of the Italian Network for Research on Psychoses 133
Effectiveness of Intramuscular Chlorpromazine for Rapid Treatment of Psychomotor Agitation: A Naturalistic, Retrospective, and Observational Study 131
Unraveling the Boundaries, Overlaps, and Connections between Schizophrenia and Obsessive–Compulsive Disorder (OCD) 128
Principi di farmacodinamica e farmacocinetica nello switch tra antipsicotici: focus su cariprazina 127
Insights into the Incidence, Course, and Management of Lithium-Induced Hypothyroidism in Real-World Psychiatric Practice in Italy 124
Exploratory study of ultraviolet B (UVB) radiation and age of onset of bipolar disorder 124
Efficacy and safety of ketamine and esketamine for unipolar and bipolar depression: an overview of systematic reviews with meta-analysis 124
Medico-legal implications of mobbing: a case law [Riflessioni medico-legali su un caso giudiziario di mobbing] 124
Personalized treatment of depression phenotypes: Role of trazodone in depression with insomnia 124
The influence of autistic symptoms on social and non-social cognition and on real-life functioning in people with schizophrenia: Evidence from the Italian Network for Research on Psychoses multicenter study 120
Variations in seasonal solar insolation are associated with a history of suicide attempts in bipolar I disorder 116
Erratum: Safety of psychotropic medications in people with COVID-19: Evidence review and practical recommendations (BMC Medicine (2020) 18 (215) DOI: 10.1186/s12916-020-01685-9) 114
Genetic determinants of coping, resilience and self-esteem in schizophrenia suggest a primary role for social factors and hippocampal neurogenesis 112
Factors Associated With Real-Life Functioning in Persons With Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses 112
Vulnerabilities in Mental Health due to Covid-19 Pandemic: The Response of the Italian Physicians 111
Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 mg/1.3 ml immediate release 111
Treatment persistence with aripiprazole once monthly: a 4-year follow-up 106
Impact of menstrual cycle events on bipolar disorder course: a narrative review of current evidence 106
Personalized medicine with extended-release trazodone and/or once-a-day trazodone: From research trials to clinical practice 106
Investigating the Relationship between Autistic Traits, Ruminative Thinking, and Suicidality in a Clinical Sample of Subjects with Bipolar Disorder and Borderline Personality Disorder 106
Drug-drug interactions between COVID-19 therapeutics and psychotropic medications 106
Autistic symptoms in unaffected first-degree relatives of people with schizophrenia: results from the Italian Network for Research on Psychoses multicenter study 104
Interplay Among Psychopathologic Variables, Personal Resources, Context-Related Factors, and Real-life Functioning in Individuals With Schizophrenia: A Network Analysis 103
Genome-wide association study detected novel susceptibility genes for social cognition impairment in people with schizophrenia 100
Rethinking the role of trazodone in the different depressive dimensions 99
Individualized strategies for depression: narrative review of clinical profiles responsive to vortioxetine 99
Prolonged grief disorder in psychiatric patients: Assessing the PG-13-R scale and clinical implications 98
Practical prescribing with COVID-19 medications and psychotropics: a guide to pharmacokinetic interactions 93
Pocket Guide to Practical Psychopharmacology : Lithium and Anticonvulsants in Psychiatric Practice 92
Employment and Social Security/Insurance among patients affected by mental disorders in Italy: A descriptive multi-center study 85
Liquid antipsychotics in the management of psychomotor agitation: a focus on promazine 83
Prevalence of antipsychotic-induced extrapyramidal symptoms and their association with neurocognition and social cognition in outpatients with schizophrenia in the "real-life" 82
Intravenous trazodone for the treatment of psychomotor agitation and associated symptoms in major depressive disorder patients experiencing a depressive episode with mixed features 79
Rehabilitation in adults with complex psychosis: a clinician-oriented narrative review of multidimensional approaches to functional recovery 30
Valproate-enhanced Protocols for alcohol withdrawal syndrome: a brief review and retrospective study of efficacy and the ability to reduce benzodiazepine use 19
Inflammatory and Immune Biomarkers in Mood Disorders: From Mechanistic Pathways to Clinical Translation 12
Long-Acting Injectable Antipsychotics in Adolescents: From Current Evidence and Gaps to Clinical Practice 10
Efficacy and Tolerability of Bupropion in Major Depressive Disorder with Comorbid Anxiety Symptoms: A Systematic Review 9
Totale 16.380
Categoria #
all - tutte 50.642
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.642


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022719 0 82 57 74 42 40 63 46 82 48 58 127
2022/2023937 55 60 133 86 58 151 29 143 95 44 39 44
2023/20241.378 77 36 96 90 50 284 341 42 18 99 113 132
2024/20253.334 112 146 227 329 366 283 143 141 255 255 347 730
2025/20266.777 546 892 653 785 1.042 294 698 279 252 393 343 600
2026/2027486 356 130 0 0 0 0 0 0 0 0 0 0
Totale 16.380